{"id":"https://openalex.org/A5115632708","orcid":null,"observed_orcids":[],"display_name":"Amal Alnajjar","raw_author_names":["A Alnajjar","Amal Alnajjar"],"full_name":"Amal Alnajjar","works_count":4,"cited_by_count":9,"summary_stats":{"2yr_mean_citedness":2.25,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5115632708","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210127754","ror":"https://ror.org/030atj633","display_name":"Ministry of Health","country_code":"SA","type":"government","lineage":["https://openalex.org/I4210127754"]},"years":[2024]},{"institution":{"id":"https://openalex.org/I4210130698","ror":"https://ror.org/035n3nf68","display_name":"Security Forces Hospital","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I4210130698"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4210130698","ror":"https://ror.org/035n3nf68","display_name":"Security Forces Hospital","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I4210130698"]}],"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","count":3,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","count":2,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12400","display_name":"Neurogenetic and Muscular Disorders Research","count":2,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","count":1,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12400","display_name":"Neurogenetic and Muscular Disorders Research","value":2.53e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","value":1.46e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","value":1.33e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","value":7.9e-06,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","value":4e-06,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9713850021362305},{"id":"2778558090","wikidata":"https://www.wikidata.org/wiki/Q580290","display_name":"Spinal muscular atrophy","score":0.8647268414497375},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.761900007724762},{"id":"2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","score":0.36910000443458557},{"id":"126451531","wikidata":"https://www.wikidata.org/wiki/Q2852035","display_name":"Years of potential life lost","score":0.274399995803833}],"counts_by_year":[{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2025,"works_count":1,"oa_works_count":1,"cited_by_count":1},{"year":2026,"works_count":2,"oa_works_count":2,"cited_by_count":8}],"display_name_alternatives":["A Alnajjar","Amal Alnajjar"],"block_key":"a alnajjar","works_api_url":"https://api.openalex.org/works?filter=author.id:A5115632708","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5115632708","updated_date":"2026-11-12T13:17:38","created_date":"2024-12-25T00:00:00"}